share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  10/01 18:08

牛牛AI助理已提取核心訊息

The United States Securities and Exchange Commission (SEC) has declared the Form S-3 filing by 60 Degrees Pharmaceuticals, Inc. effective as of September 30, 2024, at 4:05 PM. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this filing, under file number 333-282221, indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to proceed with the issuance of securities as detailed in their submission to the SEC.
The United States Securities and Exchange Commission (SEC) has declared the Form S-3 filing by 60 Degrees Pharmaceuticals, Inc. effective as of September 30, 2024, at 4:05 PM. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this filing, under file number 333-282221, indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to proceed with the issuance of securities as detailed in their submission to the SEC.
美國證券交易委員會(SEC)已宣佈60 Degrees Pharmaceuticals, Inc.提交的S-3表格於2024年9月30日下午4:05生效。這個表格是一份註冊聲明,允許公司向公衆發行各種證券。根據文件編號333-282221,該文件的生效表明60 Degrees Pharmaceuticals已滿足所有必要的監管要求,可以繼續按照其提交給SEC的說明發行證券。
美國證券交易委員會(SEC)已宣佈60 Degrees Pharmaceuticals, Inc.提交的S-3表格於2024年9月30日下午4:05生效。這個表格是一份註冊聲明,允許公司向公衆發行各種證券。根據文件編號333-282221,該文件的生效表明60 Degrees Pharmaceuticals已滿足所有必要的監管要求,可以繼續按照其提交給SEC的說明發行證券。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。